Elliot Shapiro’s practice is transaction-oriented, with a focus on corporate and securities law, public and private mergers & acquisitions (M&A), infrastructure and P3 financing, as well as venture capital financing transactions. Mr. Shapiro also regularly advises public companies and their boards of directors on strategic, disclosure and governance matters. He has also worked on various licensing and related commercial arrangements. Mr. Shapiro has been integrally involved in numerous cross-border Canada-US corporate finance transactions both on a public and private placement basis, as well as a range of public and private M&A transactions. Mr. Shapiro is co-Chair of our Canadian corporate finance and securities team and a member of the Corporate Finance Advisory Committee of the Québec Autorité des marchés financiers. Mr. Shapiro also serves as a member of Norton Rose Fulbright’s Canadian Risk and Audit Committee. He previously served for over five years as Corporate Secretary of Aeterna Zentaris Inc., a specialty biopharmaceutical company traded on the Toronto Stock Exchange and the Nasdaq Capital Market.